CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- 4 Grant or award Director acquired 11,247 shares (grant or award)
- 4 Grant or award Director acquired 11,247 shares (grant or award)
- 4 Grant or award Director acquired 11,247 shares (grant or award)
- 4 Grant or award Director acquired 11,247 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 35,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 35,000 shares (grant or award)
- 4 Grant or award Chief Product Officer acquired 35,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 47,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 108,000 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Product Officer bought 33,350 shares at $17.00 ($566,950)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 15 · 290 filings